{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T15:14:54Z","timestamp":1788448494476,"version":"build-2803163510"},"reference-count":47,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["mp.uscap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Modern Pathology"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.modpat.2024.100536","type":"journal-article","created":{"date-parts":[[2024,6,12]],"date-time":"2024-06-12T16:56:55Z","timestamp":1718211415000},"page":"100536","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["ALK-Rearranged Renal Cell Carcinoma: A Multi-Institutional Study of 9 Cases With Expanding the Morphologic and Molecular Genetic Spectrum"],"prefix":"10.1016","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5971-7303","authenticated-orcid":false,"given":"Ming","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaona","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoqun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hualei","family":"Gan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ni","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangjie","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanfeng","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaodong","family":"Teng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayun","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shan","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaotong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6470-9017","authenticated-orcid":false,"given":"Lisong","family":"Teng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.modpat.2024.100536_bib1","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1038\/s41379-021-00737-6","article-title":"Novel, emerging and provisional renal entities: the Genitourinary Pathology Society (GUPS) update on renal neoplasia","volume":"34","author":"Trpkov","year":"2021","journal-title":"Mod Pathol"},{"key":"10.1016\/j.modpat.2024.100536_bib2","doi-asserted-by":"crossref","first-page":"168","DOI":"10.3390\/cancers12010168","article-title":"ESC, ALK, HOT and LOT: three letter acronyms of emerging renal entities knocking on the door of the WHO classification","volume":"12","author":"Siadat","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.modpat.2024.100536_bib3","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1002\/gcc.23007","article-title":"Translocation carcinomas of the kidney","volume":"61","author":"Argani","year":"2022","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.modpat.2024.100536_bib4","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1038\/modpathol.2012.107","article-title":"ALK alterations in adult renal cell carcinoma: frequency, clinicopathologic features and outcome in a large series of consecutively treated patients","volume":"25","author":"Sukov","year":"2012","journal-title":"Mod Pathol"},{"key":"10.1016\/j.modpat.2024.100536_bib5","doi-asserted-by":"crossref","first-page":"4427","DOI":"10.1002\/cncr.27391","article-title":"Identification of anaplastic lymphoma kinase fusions in renal cancer: large-scale immunohistochemical screening by the intercalated antibody-enhanced polymer method","volume":"118","author":"Sugawara","year":"2012","journal-title":"Cancer"},{"key":"10.1016\/j.modpat.2024.100536_bib6","doi-asserted-by":"crossref","first-page":"452","DOI":"10.4132\/KoreanJPathol.2013.47.5.452","article-title":"ALK-positive renal cell carcinoma in a large series of consecutively resected Korean renal cell carcinoma patients","volume":"47","author":"Lee","year":"2013","journal-title":"Korean J Pathol"},{"key":"10.1016\/j.modpat.2024.100536_bib7","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/modpathol.2010.213","article-title":"Renal cell carcinoma with novel VCL-ALK fusion: new representative of ALK-associated tumor spectrum","volume":"24","author":"Debelenko","year":"2011","journal-title":"Mod Pathol"},{"key":"10.1016\/j.modpat.2024.100536_bib8","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1002\/gcc.20839","article-title":"ALK rearrangement in sickle cell trait-associated renal medullary carcinoma","volume":"50","author":"Mari\u00f1o-Enr\u00edquez","year":"2011","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.modpat.2024.100536_bib9","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1097\/PAS.0000000000000179","article-title":"VCL-ALK renal cell carcinoma in children with sickle-cell trait: the eighth sickle-cell nephropathy?","volume":"38","author":"Smith","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.modpat.2024.100536_bib10","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/j.prp.2016.07.004","article-title":"TFE3-positive renal cell carcinomas are not always Xp11 translocation carcinomas: report of a case with a TPM3-ALK translocation","volume":"212","author":"Thorner","year":"2016","journal-title":"Pathol Res Pract"},{"key":"10.1016\/j.modpat.2024.100536_bib11","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1097\/PAS.0000000000000610","article-title":"Two cases of renal cell carcinoma harboring a novel STRN-ALK fusion gene","volume":"40","author":"Kusano","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.modpat.2024.100536_bib12","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1002\/gcc.22346","article-title":"ALK-rearranged renal cell carcinomas in children","volume":"55","author":"Cajaiba","year":"2016","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.modpat.2024.100536_bib13","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1002\/gcc.22382","article-title":"Expanding the spectrum of ALK-rearranged renal cell carcinomas in children: identification of a novel HOOK1-ALK fusion transcript","volume":"55","author":"Cajaiba","year":"2016","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.modpat.2024.100536_bib14","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/his.13185","article-title":"Genetic analysis and clinicopathological features of ALK-rearranged renal cell carcinoma in a large series\u00a0of resected Chinese renal cell carcinoma patients and literature review","volume":"71","author":"Yu","year":"2017","journal-title":"Histopathology"},{"key":"10.1016\/j.modpat.2024.100536_bib15","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.cancergen.2017.11.010","article-title":"ALK-TPM3 rearrangement in adult renal cell carcinoma: report of a new case showing loss of chromosome 3 and literature review","volume":"221","author":"Bodokh","year":"2018","journal-title":"Cancer Genet"},{"key":"10.1016\/j.modpat.2024.100536_bib16","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.eururo.2018.03.032","article-title":"Responses to Alectinib in ALK-rearranged papillary renal cell carcinoma","volume":"74","author":"Pal","year":"2018","journal-title":"Eur Urol"},{"key":"10.1016\/j.modpat.2024.100536_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1200\/PO.18.00185","article-title":"ALK fusions in renal cell carcinoma: response to Entrectinib","volume":"2","author":"Tao","year":"2018","journal-title":"JCO Precis Oncol"},{"key":"10.1016\/j.modpat.2024.100536_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2019.152651","article-title":"Targeted next-generation sequencing revealed distinct clinicopathologic and molecular features of VCL-ALK RCC: a unique case from an older patient without clinical evidence of sickle cell trait","volume":"215","author":"Wang","year":"2019","journal-title":"Pathol Res Pract"},{"key":"10.1016\/j.modpat.2024.100536_bib19","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1186\/s13000-019-0879-0","article-title":"ALK-TPM3 rearrangement in adult renal cell carcinoma: a case report and literature review","volume":"14","author":"Yang","year":"2019","journal-title":"Diagn Pathol"},{"key":"10.1016\/j.modpat.2024.100536_bib20","doi-asserted-by":"crossref","first-page":"262","DOI":"10.3349\/ymj.2020.61.3.262","article-title":"Characteristics of renal cell carcinoma harboring TPM3-ALK fusion","volume":"61","author":"Woo","year":"2020","journal-title":"Yonsei Med J"},{"key":"10.1016\/j.modpat.2024.100536_bib21","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1007\/s00428-020-02752-5","article-title":"ALK-rearranged renal cell carcinoma with a novel PLEKHA7-ALK translocation and metanephric adenoma-like morphology","volume":"476","author":"Hang","year":"2020","journal-title":"Virchows Arch"},{"key":"10.1016\/j.modpat.2024.100536_bib22","doi-asserted-by":"crossref","first-page":"2564","DOI":"10.1038\/s41379-020-0578-0","article-title":"ALK rearranged renal cell carcinoma (ALK-RCC): a multi-institutional study of twelve cases with identification of novel partner genes CLIP1, KIF5B and KIAA1217","volume":"33","author":"Kuroda","year":"2020","journal-title":"Mod Pathol"},{"key":"10.1016\/j.modpat.2024.100536_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2020.153286","article-title":"ALK rearrangement in TFE3-positive renal cell carcinoma: alternative diagnostic option to exclude Xp11.2 translocation carcinoma","volume":"216","author":"Zhu","year":"2020","journal-title":"Pathol Res Pract"},{"key":"10.1016\/j.modpat.2024.100536_bib24","doi-asserted-by":"crossref","first-page":"2855","DOI":"10.21037\/tau-20-1343","article-title":"Anaplastic lymphoma kinase (ALK) rearrangement in adult renal cell carcinoma with lung metastasis: a case report and literature review","volume":"9","author":"Zhou","year":"2020","journal-title":"Transl Androl Urol"},{"key":"10.1016\/j.modpat.2024.100536_bib25","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1177\/10668969211003660","article-title":"ALK-rearranged renal cell carcinoma (RCC): a report of 2 cases and review of the literature emphasizing the distinction between VCL-ALK and non-VCL-ALK RCC","volume":"29","author":"Wangsiricharoen","year":"2021","journal-title":"Int J Surg Pathol"},{"key":"10.1016\/j.modpat.2024.100536_bib26","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s13000-022-01238-z","article-title":"ALK rearrangement-associated renal cell carcinoma morphologically mimicking mucinous tubular and spindle cell carcinoma: a case report","volume":"17","author":"Kai","year":"2022","journal-title":"Diagn Pathol"},{"key":"10.1016\/j.modpat.2024.100536_bib27","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1007\/s00428-022-03451-z","article-title":"ALK-rearranged renal cell carcinoma with TPM3::ALK gene fusion and review of the literature","volume":"482","author":"Galea","year":"2023","journal-title":"Virchows Arch"},{"key":"10.1016\/j.modpat.2024.100536_bib28","article-title":"Exploration of clinicopathological features of rearranged renal cell carcinoma and TFE3, TFEB, and ALK staining performance in renal entities","volume":"9","author":"Liu","year":"2023","journal-title":"Heliyon"},{"key":"10.1016\/j.modpat.2024.100536_bib29","series-title":"WHO Classification of Tumors","first-page":"82","article-title":"ALK-rearranged renal cell carcinomas","author":"Argani","year":"2022"},{"key":"10.1016\/j.modpat.2024.100536_bib30","doi-asserted-by":"crossref","first-page":"3995","DOI":"10.3390\/ijms23073995","article-title":"Activity of ALK inhibitors in renal cancer with ALK alterations: a systematic review","volume":"23","author":"Iannantuono","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.modpat.2024.100536_bib31","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1097\/PAS.0b013e31816a1c34","article-title":"Papillary renal cell carcinoma with low-grade spindle cell foci: a mimic of mucinous tubular and spindle cell carcinoma","volume":"32","author":"Argani","year":"2008","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.modpat.2024.100536_bib32","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1182\/blood.V89.4.1394","article-title":"Detection of anaplastic lymphoma kinase (ALK) and nucleolar protein nucleophosmin (NPM)-ALK proteins in normal and neoplastic cells with the monoclonal antibody ALK1","volume":"89","author":"Pulford","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.modpat.2024.100536_bib33","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1126\/science.8122112","article-title":"Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin's lymphoma","volume":"263","author":"Morris","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.modpat.2024.100536_bib34","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/S0002-9440(10)64550-6","article-title":"TPM3-ALK and TPM4-ALK oncogenes in inflammatory myofibroblastic tumors","volume":"157","author":"Lawrence","year":"2000","journal-title":"Am J Pathol"},{"key":"10.1016\/j.modpat.2024.100536_bib35","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/nature05945","article-title":"Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer","volume":"448","author":"Soda","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.modpat.2024.100536_bib36","doi-asserted-by":"crossref","first-page":"4233","DOI":"10.1073\/pnas.1321937111","article-title":"Identification of the transforming STRN-ALK fusion as a potential therapeutic target in the aggressive forms of thyroid cancer","volume":"111","author":"Kelly","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.modpat.2024.100536_bib37","first-page":"3829","article-title":"The potential diagnostic and predictive role of anaplastic lymphoma kinase (ALK) gene alterations in melanocytic tumors","volume":"24","author":"Ronchi","year":"2020","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"10.1016\/j.modpat.2024.100536_bib38","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1038\/modpathol.2015.49","article-title":"ALK rearrangement and overexpression in epithelioid fibrous histiocytoma","volume":"28","author":"Doyle","year":"2015","journal-title":"Mod Pathol"},{"key":"10.1016\/j.modpat.2024.100536_bib39","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1158\/2159-8290.CD-12-0009","article-title":"ALKoma: a cancer subtype with a shared target","volume":"2","author":"Mano","year":"2012","journal-title":"Cancer Discov"},{"key":"10.1016\/j.modpat.2024.100536_bib40","doi-asserted-by":"crossref","first-page":"594","DOI":"10.2174\/187152007784111340","article-title":"Oncogenic fusion tyrosine kinases as molecular targets for anti-cancer therapy","volume":"7","author":"Gunby","year":"2007","journal-title":"Anticancer Agents Med Chem"},{"key":"10.1016\/j.modpat.2024.100536_bib41","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1001\/jamaoncol.2017.2918","article-title":"Identification of ALK rearrangements in malignant peritoneal mesothelioma","volume":"4","author":"Hung","year":"2018","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.modpat.2024.100536_bib42","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1097\/PAS.0000000000001656","article-title":"Pediatric mesothelioma with ALK fusions: a molecular and pathologic study of 5 cases","volume":"45","author":"Argani","year":"2021","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.modpat.2024.100536_bib43","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1097\/00000478-199706000-00001","article-title":"Papillary (chromophil) renal cell carcinoma: histomorphologic characteristics and evaluation of conventional pathologic prognostic parameters in 62 cases","volume":"21","author":"Amin","year":"1997","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.modpat.2024.100536_bib44","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.anndiagpath.2017.11.004","article-title":"Chromosomal numerical aberration pattern in papillary renal cell carcinoma: review article","volume":"40","author":"Pitra","year":"2019","journal-title":"Ann Diagn Pathol"},{"key":"10.1016\/j.modpat.2024.100536_bib45","doi-asserted-by":"crossref","first-page":"3939","DOI":"10.3390\/ijms20163939","article-title":"Fluorescence in situ hybridization (FISH) for detecting anaplastic lymphoma kinase (ALK) rearrangement in lung cancer: clinically relevant technical aspects","volume":"20","author":"Tang","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.modpat.2024.100536_bib46","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1634\/theoncologist.2016-0488","article-title":"ALK fusions in a wide variety of tumor types respond to anti-ALK targeted therapy","volume":"22","author":"Ross","year":"2017","journal-title":"Oncologist"},{"key":"10.1016\/j.modpat.2024.100536_bib47","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.phrs.2017.01.007","article-title":"Anaplastic lymphoma kinase (ALK) inhibitors in the treatment of ALK-driven lung cancers","volume":"117","author":"Roskoski","year":"2017","journal-title":"Pharmacol Res"}],"container-title":["Modern Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395224001169?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395224001169?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T03:59:30Z","timestamp":1762315170000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0893395224001169"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":47,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["S0893395224001169"],"URL":"https:\/\/doi.org\/10.1016\/j.modpat.2024.100536","relation":{},"ISSN":["0893-3952"],"issn-type":[{"value":"0893-3952","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"ALK-Rearranged Renal Cell Carcinoma: A Multi-Institutional Study of 9 Cases With Expanding the Morphologic and Molecular Genetic Spectrum","name":"articletitle","label":"Article Title"},{"value":"Modern Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.modpat.2024.100536","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 United States & Canadian Academy of Pathology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100536"}}